U.S. Senator Marco Rubio’s (R-FL) office will host in-person and virtual Mobile Office Hours next week to assist constituents with federal casework issues in their respective local communities. These office hours offer constituents who do not live close to one of...
On March 1, 2024, Italian Prime Minister Giorgia Meloni will make her second official visit to the United States. Ahead of this occasion, U.S. Senator Marco Rubio (R-FL) issued a statement highlighting the need to maintain and strengthen U.S.-Italy relations. “Once...
Guatemala is one of seven countries in Latin America and the Caribbean that maintains diplomatic relations with Taiwan. U.S. Senator Marco Rubio (R-FL), and Senators Jeff Merkley (D-OR), Chuck Grassley (R-IA), Tim Kaine (D-VA), John Boozman (R-AR), Roger Wicker...
The U.S. Department of Veterans Affairs (VA) has rolled out a web-based travel reimbursement program to replace its paper claim system used to reimburse veterans for travel expenses to and from medical appointments. However, veterans nationwide are experiencing issues...
U.S. Senator Marco Rubio (R-FL) led an effort to overturn a Biden Administration rule that would send American tax dollars to Chinese competitors by waiving the Buy America requirements for electric vehicle (EV) charging stations. President Joe Biden vetoed the...
U.S. Senators Marco Rubio (R-FL) and Mark Warner (D-VA), Vice Chairman and Chairman, respectively, of the Senate Select Committee on Intelligence sent a letter to U.S. Secretary of Commerce Gina Raimondo expressing the urgent need to strengthen the Commerce...
Rubio, Duckworth Question NIH on Omission of Goal to “Lengthen Life”
The National Institutes of Health (NIH) recently revised its mission statement by eliminating its commitment to “lengthen life,” raising concerns about its approach to a
U.S. Senators Marco Rubio (R-FL) and Tammy Duckworth (D-IL) sent a letter to NIH Director Dr. Monica Bertagnolli requesting an explanation for this alarming change.
- “We are concerned that eliminating the stated goal of lengthening life within the NIH’s mission statement without explanation or justification could have a negative impact on people’s existing attitudes towards the quality of life of people with disabilities.”
The full text of the letter is below.
Dear Director Bertagnolli:
The National Institutes of Health (NIH) funds critical research that aims to address some of the most important health challenges of our time. Researchers, physicians, policymakers, and patients alike all look to the agency’s mission and work to inform their approach to healthcare. On August 25, 2023, your agency released a proposed change to its mission statement that would, among other things, remove “lengthen life” from NIH’s stated goals. We write to express concern about the potential effects of this change and to request information as to why this change was made.
Amid the rising openness of some countries, such as Canada and the Netherlands, as well as a handful of states toward physician-assisted suicide, we are concerned that eliminating the stated goal of lengthening life within the NIH’s mission statement without explanation or justification could have a negative impact on people’s existing attitudes towards the quality of life of people with disabilities. People with disabilities deserve to be treated with the same dignity and respect as non-disabled people, but stereotypes and bias in the research and healthcare sectors continue to prevent people with disabilities from getting the care they need, when they need it. One survey found that over 80 percent of U.S. physicians who responded said they believe people with a significant disability have a worse quality of life than nondisabled people. Evidence suggests this could lead to discrimination in how doctors recommend physician-assisted suicide. With such pervasive, harmful views impacting so many Americans, it is imperative that the mission of the nation’s biggest funder of biomedical research be crystal clear.
While we applaud the NIH for recognizing the disparity in current healthcare research and delivery for people with disabilities, we remain concerned about the proposal to remove “lengthen life” from the NIH’s overall mission statement. To better understand why NIH is proposing this change, we request a staff-level briefing to discuss this issue, as well as your response to the following questions:
- What motivated your decision to remove “lengthen life” from the NIH mission statement?
- Were outside groups consulted in the decision-making process? If so, which organizations, and what were their recommendations?
- What, if any, effect will deleting the phrase “lengthen life” have on the work of the NIH in its research and grant-making priorities? What guidance will be provided to program officers and other relevant personnel?
Thank you for your attention to this matter. We look forward to your response.